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Overview

Learning Objectives

As the population ages and longevity increases, there is a
growing incidence of what demographers term “old old”
patients incurring hip fractures. In light of poor outcomes with
nonoperative management, orthopedic surgeons must decide
which patients are too ill, too frail, or too old for surgical
treatment. This controversy faces orthopedic surgeons every
day and around the world. The preoperative factors associated
with overall increased mortality are well studied and have
historically included older age, poor baseline mental and ambulatory status, and multiple chronic diseases [1, 8, 20].
The impetus to conduct this investigation was based on an
anecdotal observation by the senior author that nonagenarians
appeared to have similar 30-day outcomes as his younger (yet
elderly) hip fracture patients. To understand this phenomenon
and to test its assumption, several lines of inquiry were initiated
to investigate if our nonagenarians who sustained hip fractures
had attributes which were special or distinct from other previously studied samples, if our treatment strategy was unique, or
if there were innate protective factors in individuals whose
survival reached a tenth decade. To address these questions,
we chose to examine the conventional predictors of mortality
after hip fracture and employed a post-hoc risk schema which
had previously been applied in this fashion. Multiple authors
have described the increasing odds of 30-day mortality in older
groups of patients, specifically patients over 90 [18, 23].
Given the observation that age did not seem to be a risk
factor for mortality in our cohort, our study attempts to answer
the following three questions: 1) do patients 90 years and older
in our cohort have different preoperative laboratory, clinical,
and injury characteristics than younger patients with the same
injury? 2) What potentially modifiable contributing risk factors (demographic, laboratory findings, and clinical) were
associated with 30-day mortality and were there differences
between our older and younger cohorts for this outcome?

Hospital for Special Surgery professional education activities
are intended to improve knowledge, competence, and performance of our learners and to lead to better patient care. At the
conclusion of the activity, the participant should be able to:
& Identify comorbid predictors, other than 90+ years of age,
such as low scoring on mental status tests, age, body mass
index (BMI), and history of malignancy, for patients who
suffered from hip fractures within 30 days.
& Implement appropriate treatments to practice for at-risk hip
lfracture patients, including counseling of patients and families on postoperative risks and whether or not surgery is an
appropriate treatment.

Target Audience
This activity is targeted at orthopaedic surgeons, primary
care physicians, rheumatologists, gerontologists, specialty
physicians, physician assistants, residents, fellows and medical students.

Accreditation
Hospital for Special Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.

Credit Designation
Hospital for Special Surgery designates this journal-based
CME activity for a maximum of 1.0 AMA PRA Category 1
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Abstract Background: In light of poor outcomes with
nonoperative management of hip fractures, orthopedic surgeons are faced with difficult decisions about which patients
are too ill or too old for surgical treatment. Questions/
Purposes: This study sought to investigate if patients over
90 years had different preoperative laboratory, clinical, and
injury characteristics than younger patients with the same
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injury. We compared our cohort with previously published
data. We wished to identify if there were pre-injury risk factors
associated with 30-day mortality, which could be modified to
enhance postoperative outcomes. Methods: This is a retrospective review of 198 operatively managed hip fractures in patients 75 years or older. We collected data on demographics,
select preoperative laboratory values, injury type, comorbidities, and 30-day mortality. Results: Eleven (5.6%) of the cohort
died within 30 days of surgery, 6.3% in the younger group, and
3.7% in the older group; the difference was not statistically
significant. For baseline characteristics, there was no difference between the age groups for pre-injury comorbidities,
hemoglobin, serum albumin, BUN, prevalence of UTI, or
fracture type. A total of 67 (35.8%) patients had evidence of
UTI on admission. Conclusions: These findings reveal that in
our dichotomized cohort, pre-injury characteristics were similar and age alone was not an independent predictor of mortality. These data may inform decision-making for orthopedic
surgeons and the medical providers who consult to optimize
these patients for surgery. We identified high rates of UTI in
both age groups, a potentially remediable factor to optimize
outcomes in hip fracture surgery in elderly patients.
Keywords fragility fractures . orthopedic . postoperative .
geriatrics . comorbidity . mortality
Introduction
Hip fractures are a significant cause of morbidity, mortality,
and health care consumption in the elderly, accounting for
258,000 hospital admissions per year in the USA [13].
Incidence increases with age and is principally in women
[3, 8]. Although there is evidence that incidence of hip
fracture is declining, prevalence of comorbidities among
these patients is increasing [4]. Worldwide total number of
hip fractures has been estimated to exceed 6 million by 2050
[16]. As the population ages and longevity increases, there
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is a growing incidence of what demographers term “old old”
patients incurring hip fractures. In light of poor outcomes
with nonoperative management, orthopedic surgeons must
decide which patients are too ill, too frail, or too old for
surgical treatment. This controversy faces orthopedic surgeons
every day and around the world. The preoperative factors
associated with overall increased mortality are well studied
and have historically included older age, poor baseline mental
and ambulatory status, and multiple chronic diseases [1, 8, 20].
Independent predictors of 30-day mortality include advanced
age, male gender, several comorbidities, poor mini-mental
admission test score, hemoglobin concentration less than
10 g/dL, institutionalization, and malignant disease [9, 19, 21,
24]. Preoperative risk assessment tools such as the Nottingham
hip fracture score, POSSUM, and American Society of Anesthesiologists (ASA) and NSQIP have been developed to help
guide treatment decisions [17, 19, 21, 23]. The presence of two
or more comorbid conditions has been identified as a harbinger
of poor outcomes [18, 19, 24]. Previously and extensively used
to predict mortality in medical patients, the Charlson comorbidity index (CCI) uses a weighted score for 21 comorbidities
associated with mortality [6, 22]. In a cohort of hip fracture
patients, a Charlson score of greater than 6 has been shown to
double the odds ratio for mortality within 30 days [18].
The impetus to conduct this investigation was based on
an anecdotal observation by the senior author that nonagenarians appeared to haxve similar 30-day outcomes as his
younger (yet elderly) hip fracture patients. To understand
this phenomenon and to test its assumption, several lines of
inquiry were initiated to investigate if our nonagenarians
who sustained hip fractures had attributes which were special or distinct from other previously studied samples, if our
treatment strategy was unique, or if there were innate protective factors in individuals whose survival reached a tenth
decade. To address these questions, we chose to examine the
conventional predictors of mortality after hip fracture and
employed a post-hoc risk schema which had previously
been applied in this fashion. Multiple authors have described the increasing odds of 30-day mortality in older
groups of patients, specifically patients over 90 [18, 24].
Given the observation that age did not seem to be a risk
factor for mortality in our cohort, our study attempts to
answer the following three questions: 1) Do patients 90 years
and older in our cohort have different preoperative laboratory, clinical, and injury characteristics than younger patients with the same injury? 2) How does our cohort
compare with US and international data; are our results
generalizable or is our cohort unique [5, 15, 18, 19, 24]?
3) What potentially modifiable contributing risk factors
(demographic, laboratory findings, and clinical) were associated with 30-day mortality and were there differences
between our older and younger cohorts for this outcome?
Patients and Methods
This retrospective case control study was conducted at two
tertiary care, teaching hospitals on Long Island, NY. All
operative hip fracture patients meeting inclusion criteria
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from June 2011 to December 2013 were included in a
retrospective review of cases from one fellowship-trained
orthopedic trauma surgeon’s hip fracture database. Patients
included in the study were geriatric hip fracture patients
treated operatively by the senior author. Pertrochanteric
fractures were treated with dynamic hip screw, or
cephalomedullary nail and femoral neck fractures were
treated with open reduction internal fixation (ORIF),
hemiarthroplasty, or total hip arthroplasty. Patients were
excluded if they were less than 75 years of age, suffered
high-energy trauma, or had nonoperatively managed hip
fractures or pathologic fractures. All patients were assessed
and treated using an algorithmic approach (Fig. 1).
Baseline characteristics that were recorded included age,
gender, fracture type, calculation of pre-injury comorbid disease states, admission hemoglobin, BUN, creatinine, albumin,
and the presence of urinary tract infection (UTI), defined by the
presence of positive urine culture or leukocyte esterase, or
nitrates, on urine analysis. All laboratory results collected were
from a single preoperative value at time of admission. We
defined injury types as follows: femoral neck (AO/OTA 31B) and pertrochanteric (AO/OTA 31-A). To categorize comorbidities, we used the Charlson comorbidity index, a widely
employed, validated instrument for predicting mortality using a
composite score in which weights are assigned to commonly
encountered conditions [6]. One-point conditions were myocardial infarction, congestive heart failure, peripheral vascular
disease, cerebrovascular disease, dementia, chronic pulmonary
disease, connective tissue disease, ulcer disease, mild liver
disease, and diabetes; two-point conditions were hemiplegia,
moderate or severe renal disease, diabetes with end organ
damage, and any malignancy; and three-point conditions were
moderate or severe liver disease, and metastatic solid tumor or
AIDS were associated with a weight of six points [6].
The medical records of 255 consecutive patients within
the surgeon’s database were examined. Fifty-seven (22.4%)
of patients were excluded. All of those excluded were under
75 years of age. Among the patients 75 years or older, there
were none with high-energy trauma or pathological fractures. One hundred and ninety-eight (77.6%) out of 255
total consecutive patients with hip fractures in the surgeon’s
database met inclusion criteria during the study period. Of
these, 54 (27.3%) were 90 years or older. The mean age for
the older group was 93.2 (SD ±3.3), the median age in the
over 90 group was 92. Of the patients over 90 years, 16 or
29.6% were 95 or older, with the oldest patient 104. For the
75–89-year-old group, the mean age was 83.2 (SD ±3.7),
median age was 83.5. For the entire group, the mean age
was 85.9 years (SD ±5.8), median age was 85 years. Male
patients constituted 30.8% of the cohort, 31.3% of the
younger group, and 29.6% in the older group.
Our primary outcome measure was 30-day mortality.
The patients were stratified into two groups based on age
at the time of admission. The older group consisted of
patients older than 90 years, and the younger group was
patients aged 75 to 89 years. We chose the cutpoint of 75 for
the younger group to mirror a similar range of the ages we
observed in the older group (90 to 104). We examined the
same set of preoperative factors (demographics, laboratory
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255 Operative hip
fractures performed by
orthopaedic
traumatologist: June
2011- December 2013
Excluded: 57
(22.4%)
Age less than 75
years
Pathological
fractures
198 (77.6%) patients met inclusion
criteria

High energy
trauma
144 (72.3%) 75-89
years

61/144 (42.4%)
Femoral neck

83/144 (57.6%)
Pertrochanteric

7/78 (9.0%)
Femoral Neck
expired within 30
days

Collect
demographic,
laboratory,
comorbidity,
injury data

54 (27.3%) 90
years or greater

17/54(31.5%)

Femoral neck

37/54 (68.5%)
Pertrochanteric

4/120 (3.3%)
Pertrochanteric
expired within 30
days

Fig. 1. Study flow diagram.

values, comorbidities, and injury type) to correlate and
compare previously identified predictors of 30-day mortality [5, 15, 18, 19, 21, 24]. Since increasing age has previously been shown to be an independent risk factor for
mortality, this investigation focused on 30-day outcomes.
Clinical, surgical, and demographic data were abstracted
from the surgeon’s billing database and electronic medical
record systems employed by the two institutions (Sunrise
Clinical Systems and AllScripts). We used the social security death index to confirm mortality within 30 days of
surgery.
For the purpose of statistical analysis, descriptive data are
presented as frequencies and percentages for categorical variables, and means with standard deviations and medians for
continuous variables. The association between age group (75–
89 years, ≥90 years) and categorical factors was examined
using the Fisher’s exact test. The association between age
group and continuous factors was examined using the
Mann–Whitney test. The association between categorical factors and 30-day mortality was examined using the Fisher’s
exact test. The association between continuous factors and 30day mortality was examined using the Mann–Whitney test.
Results were considered statistically significant at the p<0.05

(two-sided) significance level. Data were analyzed using SAS
Version 9.3 (SAS Institute Inc., Cary, NC).
Results
No significant differences between the age groups were found
with regard to gender, preoperative hemoglobin, serum albumin, BUN, the presence of UTI, or fracture type. Serum
creatinine was marginally significant (Table 1). There were
no differences between the two age groups for the individual
Charlson comorbidities (Table 2). Sixty-nine (34.8%) of the
combined cohort had two or more of the Charlson comorbid
conditions included in the calculation of the index. The age
groups did not differ on Charlson score. The mean Charlson
score for the younger group was 1.7 (SD ±2.1) and 1.4 (SD
±1.0) for the older group. In the younger group, 15.3% had a
Charlson score in the highest two categories (≥4) compared to
1.9% of the older group; no patients in the older group had
Charlson score of 6 or greater points (Table 1). When both age
groups were combined, patients with femoral neck fracture
had a higher Charlson comorbidity index than subjects with
pertrochanteric fractures (p<0.015).
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For the outcome 30-day mortality, the 95% exact confidence interval was -13.2 to 18.2% for the difference (2.55%)
between the mortality rates. The characteristics of the patients who survived the initial 30-day postoperative period
and those who expired were compared. There were no
differences for gender, age, type of injury, comorbidity, or
preoperative laboratory values. Eleven or 5.6% of the cohort
died within 30 days of surgery: 6.3% in the younger group
and 3.7% in the older group (Table 3).
Among the patients screened on admission for urinary
tract infections, 67 (36.8% of the younger group and 33.3%
of the older group) had evidence of UTI on admission as
evidenced by positive leukocyte esterase on urine analysis.
Discussion
In our cohort of operatively managed hip fractures, we had the
anecdotal observation that patients over the age of 90 had no
worse 30-day perioperative mortality compared with our
younger patients, suggesting age is not an independent risk
factor for mortality in operative hip fracture patients. Our
analysis confirmed this observation; we observed no differences in preoperative characteristics between the age groups.
Our study was subject to several limitations: the retrospective
nature of the study precludes the ability to make causal inferences. Further, observational studies may be subject to unknown
biases, including selection bias. Our small sample size and low
Table 1 Preoperative characteristics of 155 operatively managed hip
fracture patients
75–89 years
N=144

≥90 years
N=54

Mean age, years ± SD
83.2±3.7
Median, years
83.5
Sex
Male, n (%)
45 (31.25)
Female, n (%)
99 (68.75)
Fracture type
Femoral neck, n (%)
61 (42.36)
Trochanteric, n (%)
83 (57.64)
Preop hgb, g/dL
Mean ± SD
12.5±1.6
Median
12.6
Preop creatinine, mg/dL
Mean ± SD
1.2±1.0
Median
0.9
Preop BUN, g/dLa
Mean ± SD
25.7 (12.9)
Median
22.0
Preop albumin, g/dLb
Mean ± SD
4.0 (0.4)
Median
4.0
c
Preop UTI (leukest on UA)
Positive, n (%)
50 (36.76)
Negative, n (%)
86 (63.24)
CCI score
Mean (SD)
1.7 (2.1)
Median
1.0

93.2±3.3
92.0
16 (29.63)
38 (70.37)

b

Table 2 Frequencies of Charlson comorbidities in operative managed
hip fracture patients by age cohort
ns

17 (31.48)
37 (68.52)

ns

12.2±1.5
12.1

ns

1.2±0.5
1.1

0.043

27.2 (12.3)
24.0

ns

3.9 (0.3)
3.9

ns

17 (33.33)
34 (66.67)

ns

1.4 (1.0)
1.0

ns

Sample size for BUN age 75–89: 142, age ≥90: 54
Sample size for albumin age 75–89: 131, age ≥90: 50
c
Sample size for UTI age 75–89: 136, age ≥90: 51
a

p value

event frequency leave the study relatively underpowered since it
was based on available charts and therefore not subject to a posthoc power analysis. Our results may be the reflection of the low
mortality “signal” and therefore may not represent the truth.
Further investigation as this cohort grows in size will be useful
to see if the effect holds true. Our findings may have poor
external validity as our patient population may be unique, with
overall good access to health care and very few uninsured.
We noted no clinically relevant differences between nonagenarians and the age stratum below for preoperative and injury
characteristics. Although event frequency was low, there was no
difference between age groups for 30-day mortality (Table 1). A
plausible explanation is that individuals who survive past
90 years of age have “favorable” phenotypes with cardiovascular
protective factors [2, 11, 12]. Among the nonagenarians in our
cohort, the cardiovascular profile, as categorized by the Charlson
index, was comparable to the younger group. However, overall,
our nonagenerians appear to be healthier than the younger group;
15.3% of the younger group had a Charlson score of 4 or more
compared to 1.9% of the older group. We contrasted the distribution of the Charlson comorbidities scores in our cohort with a
similar study of hip fracture patients [18] (Table 4).
We compared our patients’ characteristics and outcomes
with other hip fracture cohorts in the USA, UK, Europe, and
Asia. In contrast to several published reports, age alone did not
significantly predict 30-day mortality after hip fracture surgery
(Table 5). Few studies have specifically focused on hip fracture
characteristics and outcomes in nonagenarians with the exception of one Japanese investigation in which higher 1-year mortality was observed in patients above the age of 89 but no
differences between the groups in preoperative health as quantified using the ASA grading system [15]. Our cohort had a
higher proportion of patients 90 years or older (27.3%), was
apparently healthier, and had a higher proportion of males than
similar investigations [5, 7, 21] (Table 5).

MI
CHF
CVD
PVD
Dementia
Peptic ulcer
Mild liver disease
DM
Connective tissue
COPD
Hemiplegia
Mod–severe renal disease
DM w/ end organ damage
Tumor w/i 5 years
Leukemia
Lymphoma
Mod–severe liver dz
Metastatic solid tumor
AIDS

≥90 years

75–
89 years
N=144
N (%)

N=54
N (%)

11 (7.64)
12 (8.33)
19 (13.19)
23 (15.97)
27 (18.75)
2 (1.39)
0 (0.00)
19 (13.19)
1 (0.69)
15 (10.42)
6 (4.17)
13 (9.03)
3 (2.08)
25 (17.36)
1 (0.69)
2 (1.39)
0 (0.00)
3 (2.08)
0 (0.00)

2
10
9
6
17
1
1
5
0
3
0
4
0
5
1
0
0
0
0

(3.70)
(18.52)
(16.67)
(11.11)
(31.48)
(1.85)
(1.85)
(9.26)
(0.00)
(5.56)
(0.00)
(7.41)
(0.00)
(9.26)
(1.85)
(0.00)
(0.00)
(0.00)
(0.00)

p value

ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
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Table 3 Thirty-day mortality in operatively managed hip fracture
patients
Alive
N=187
Younger, n (%)
135 (93.75)
Older, n (%)
52 (96.30)
Male, n (%)
55 (90.16)
Female, n (%)
132 (96.35)
Fracture type
Femoral neck
71 (91.03)
Trochanteric
116 (96.67)
CCI score
Mean ± SD
1.6±1.9
Median
1.0
Preop hgb (g/dL)
Mean SD
12.4±1.6
Median
12.4
Preop creatinine (mg/dL)
Mean, SD
1.2±0.7
Median
1.0
Preop BUN (units)a
Mean, SD
25.7±12.4
Median
23.0
Preop albumin (units)b
Mean, SD
3.9±0.4
Median
4.0
Preop UTI (leukest on UA)c
Positive n (%)
61 (91.04)
Negative n (%)
116 (96.67)

Deceased
N=11

p value

9 (6.25)
2 (3.70)
6 (9.84)
5 (3.65)

ns

7 (8.97)
4 (3.33)

ns

1.8±1.2
2.0

ns

12.6±1.7
12.8

ns

1.8±2.6
0.9

ns

32.8±16.2
33.0

ns

3.7±0.5
3.8

ns

6 (8.96)
4 (3.33)

ns

ns

a

Sample size for BUN alive: 185, deceased: 11
Sample size for albumin alive: 171, deceased: 10
c
Sample size for UTI alive: 177, deceased: 10
b

This phenomenon may be explained by an aggressive
treatment strategy by the senior author. Advances in anesthesia techniques now make it possible for patients with multiple
medical comorbidities to achieve favorable outcomes and the
ability to regain pre-fracture level of function.
Compared to other investigations into short-term mortality after surgery for hip fracture, our 30-day rates were
slightly lower (5.6% versus a range from 6.3 to 9.7%) with
the exception of a Japanese investigation in which 98%
survived to 30 days [5, 15, 18, 19, 24].
Previous reports identified greater risk of femoral
neck fractures with increasing age, whereas we did not
find that age predicted the type of hip fracture. In our
cohort, patients with femoral neck fractures had a
higher Charlson score than those with pertrochanteric
fractures (p<0.01), indicating poorer overall health. This
is in contrast to previous investigations in which poor

health status predisposed patients to intertrochanteric
fractures [10].
Overall, in contrast to the US study which used the
Charlson comorbidity index, there was not a relationship
between age or high Charlson score and 30-day mortality;
our patients had lower average Charlson score and fewer
patients in the highest Charlson group [18] (Table 4).
Other reports found that patients with a diagnosis of
dementia were at increased risk of mortality [14, 18]. In
our cohort, dementia was not associated with 30-day mortality. However, 31.5% of patients over the age of 90 had a
diagnosis of dementia at baseline, compared with 18.7% in
the younger group. This difference was not statistically
significant.
It is unclear why our patient population had certain
preoperative characteristics and results that were different than other studies. One possible explanation is that
at baseline, our population has high socioeconomic status, good access to health care, positive health behaviors, and reasonably favorable nutritional status.
Moreover, a strict “door to table” protocol was observed; patients undergoing operative management of
hip fracture at our two institutions were taken to the
OR within 48 h of admission, a measure which has
been demonstrated to improve overall mortality [25,
26]. Our findings may be reflective of the standardized
technique employed by a single surgeon.
We detected unexpectedly high rates of apparent urinary tract infections on admission laboratory results in
both age groups. Although not associated with 30-day
mortality in this investigation, the presence of infection
should be considered as a potential source of perioperative
morbidity.
In conclusion, in our investigation of elderly patients
with operatively managed hip fractures, there were no differences in preoperative comorbidities and clinically relevant laboratory values between the age groups.
Additionally, there was no difference in the outcome of
30-day mortality. Our results indicate that patients over
90 years old presenting for operative management for hip
fracture are similar to those in our younger cohort. Although
not associated with poorer outcomes in this study, the high
rates of apparent UTI provide an opportunity to intervene to
mitigate the risk of potential complications. Similarly, metabolic disarray and other factors may signal cause for concern.
Notably, the findings from this investigation suggest that age
alone should not impact surgical decision-making for patients
with hip fractures. Other markers of frailty and its correlates
should be considered as they may emperil survival in elderly
patients with operative management of hip fracture. The

Table 4 Charlson comorbidity index operatively managed hip fracture patients—comparison between our study cohort and the Kirkland cohort

75–89 years
≥90 years
Total
Kirkland (64–106)

0 pts n (%)

1 pt n (%)

2–3 pts n (%)

4–5 pts n (%)

6+ pts n (%)

48 (33.33)
12 (22.22)
60 (30.30)
114 (23.5)

40 (27.78)
19 (35.19)
59 (29.80)
99 (20.4)

34 (23.61)
22 (40.74)
56 (28.28)
131 (27.0)

12 (8.33)
1 (1.85)
13 (6.57)
54 (11.1)

10 (6.94)
0 (0.00)
10 (5.05)
87 (17.9)

p value

0.0113
N/A

58 (31)
128 (69)
Excluded
ASA

78 (39.39)
120 (60.61)
Excluded
Charlson
69 (34.85)

Patients with 2 or more comorbid conditions, n (%)

7.3%
Charlson

16.2%
Modified Charlson by Deyo
(for ICD9)
(9.1)

56.1%

n/a

US, 2011
485
Retrospective
chart review
82.8 (7.8)
83 (64–106)
356 (73.4)
53 (10.9)
36 (9.7) over 75 years
96 (19.8)

Kirkland

6378 (92.5%)

n/ac

Italy, 2011
6896
Prospective cohort:
administrative data registry
n/a
83 (65–106)
5387 (78)
6.3%a

Castronuovo

1.155 (23.3)

4967 (99.9)
0
Excluded
Nottingham

n/a

UK, 2008
4967
Prospective
cohort
80
(17–102)
76.8%
390 (7.9)

Maxwell

576 (24)

57% Intracapsular,
43% extracapsular
Excludedd

465 (19)

UK, 2005
2448
Prospective
observational
82
(60–103)
1955 (80)
231 (9.6)

Roche

a

n/a data not available
Included patients managed nonoperatively
b
Solely corresponds to the amount of patients with 3 or more comorbidities, study does not include amount of patients with only 2 comorbidities
c
2,726 (39.5%) greater than 84 years
d
Excluded 358 patients including all those aged <60; those with periprosthetic fractures, pathological fractures; fractures treated without surgery; patients who died before surgery

51 (27)b

50 (26.9)

Japan, 2012
186
Retrospective
chart review
84
(65–105)
151 (81.2)
3 (1.6)

54 (27.3)

US, 2013
198
Retrospective
chart review
85.9 (5.8)
85 (75–104)
137 (69.19)
11 (5.56)

Kadowaki

90 years or more, n (%)
Type of fracture
Femoral neck
Trochanteric
% Conservative
Preop risk scoring method

Mean age (year) SD
Median age, (range)
Female gender, n (%)
30-day mortality, n (%)

Country, year
Total n
Study design

Our study

Table 5 Characteristics and outcomes: comparison between our study and other hip fracture studies
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findings in this study may inform decision-making for orthopedic surgeons and for the medical providers who consult to
clear these patients for surgery to repair hip fractures as well as
for patient and family counseling.
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CME QUESTIONS:
1) Incidence of hip fractures among very elderly individuals is decreasing.
a. True
b. False
2) Which of the following factors have not previously been
associated with mortality after hip fracture surgery?
a.
b.
c.
d.

Older age
Female gender
Poor mental status at baseline
Presence of several comorbid diseases

3) In the present study, age over 90 years was associated
with 30-day mortality.
a. True
b. False
4) Which of the following abnormal preoperative laboratory values have been associated with poor outcomes in
hip fracture patients in previous studies:
a.
b.
c.
d.
e.

Hemoglobin, BUN, HgbA1C, Creatinine, Albumin
BUN, Creatinine
Hemoglobin, HgbA1C, Albumin
BUN, Creatinine
Albumin

5) Which of the following are WELL-VALIDATED risk
scoring tools to evaluate mortality?
a.
b.
c.
d.
e.

ASA
Charlson comorbidity index
NSQIP
a, b, c
a, b

6) 30-day mortality in operative hip fracture patients has
been found to range approximately:
a.
b.
c.
d.

0–3%
4–6%
6–10%
Over 25%

7) The primary outcome measure in the present study was:
a.
b.
c.
d.

Comorbidity profile
30-day mortality
Intraoperative complication rate
90-day mortality

8) Previous reports indicate _________ risk of femoral neck
fractures with increasing age and _______ incidence of
intertrochanteric fractures with poorer health status.
a.
b.
c.
d.
e.

Similar, Increased
Similar, Similar
Decreased, Similar
Increased, Increased
Increased, Similar

9) The present study found a significant difference in
preoperative injury characteristics between patients
over 90 and a younger age group:
a. True
b. False
10) Significant differences were found in the present study
with regard to the following:
a.
b.
c.
d.
e.

Gender
Pre-operative hemoglobin
Serum albumin
Fracture type
None of the above
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